Regenerative medicine techniques like tissue regeneration are advancing rapidly, offering potential alternatives to traditional surgery for joint and tissue injuries. Governments and healthcare systems globally are debating whether to invest public resources in these emerging treatments or leave them to private markets. This reflects broader questions about innovation adoption and healthcare equity worldwide.